Neupopeg ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

neupopeg

dompé biotec s.p.a. - pegfilgrastim - neutropenia; cancer - immunostimulants, - skrajšanje trajanja nevtropenija in pojavnost vročinskih nevtropenija pri bolnikih, zdravljenih s citotoksično kemoterapijo za malignosti (razen kronično mieloično levkemijo in mielodisplastični sindrom).

Alpheon ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

alpheon

biopartners gmbh - recombinant human interferon alfa-2a - hepatitis c, kronični - immunostimulants, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.